Outcomes with MEK inhibitor therapy among adults with Langerhans cell histiocytosis (LCH): A multi-institutional study from the Adult LCH Working Group for the Histiocyte Society Meeting Abstract

  

Authors:	Goyal, G.; Acosta Medina, A. A.; Cao, X.; Bossert, D.; Matthew, P. C.; Makras, P.; Abdel-Wahab, O.; Abeykoon, J. P.; Amerikanou, R.; Bach, C.; Bennani, N. N.; Durham, B. H.; Francis, J. H.; Hook, C. C.; Lang, M.; Lacouture, M.; Petrova-drus, K.; Rech, K. L.; Rotemberg, V.; Ruan, G. J.; Shah, M. V.; Yabe, M.; Young, J. R.; Zanwar, S.; Go, R. S.; Diamond, E. L.
Abstract Title:	Outcomes with MEK inhibitor therapy among adults with Langerhans cell histiocytosis (LCH): A multi-institutional study from the Adult LCH Working Group for the Histiocyte Society
Meeting Title:	65th Annual Meeting of the American Society of Hematology (ASH)
Journal Title:	Blood
Volume:	142
Issue:	Suppl. 1
Meeting Dates:	2023 Dec 9-12
Meeting Location:	San Deigo, CA
ISSN:	0006-4971
Publisher:	American Society of Hematology
Date Published:	2023-11-01
Start Page:	4559
Language:	English
ACCESSION:	WOS:001159740308048
DOI:	10.1182/blood-2023-184911
PROVIDER:	wos
Notes:	Meeting Abstract -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/215373